International Journal of
Reproductive Biomedicine
Sat, Dec 21, 2024
[Archive]
Volume 16, Issue 11 (November 2018)
IJRM 2018, 16(11): 719-722 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Safdarian L, Ghalandarpoor Attar S N, Aleyasin A, Aghahosseini M, Sadaf Sarfjoo F, Hosseinimousa S. Investigation of anti-mullerian hormone (AMH) level and ovarian response in infertile women with endometriosis in IVF cycles. IJRM 2018; 16 (11) :719-722
URL: http://ijrm.ir/article-1-1301-en.html
URL: http://ijrm.ir/article-1-1301-en.html
Leili Safdarian1 
, Seyedeh Noushin Ghalandarpoor Attar2 , Ashraf Aleyasin1 
, Marzieh Aghahosseini1 , Fateme Sadaf Sarfjoo2 , Sedigheh Hosseinimousa * 3
, Seyedeh Noushin Ghalandarpoor Attar2 , Ashraf Aleyasin1 , Marzieh Aghahosseini1 , Fateme Sadaf Sarfjoo2 , Sedigheh Hosseinimousa * 3
1- Department of Obstetrics and Gynecology, Infertility Unit, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran
2- Department of Obstetrics and Gynecology, Infertility Unit, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran.
3- Department of Obstetrics and Gynecology, Infertility Unit, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran. ,hoseinimosa@sina.tums
2- Department of Obstetrics and Gynecology, Infertility Unit, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran.
3- Department of Obstetrics and Gynecology, Infertility Unit, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran. ,
Abstract: (3165 Views)
Background: Endometriosis, can cause ovarian conflict and reduced ovarian reserve that could lead to lower response to assisted reproductive techniques
Objective: Current study was conducted to determine the association between level of anti-mullerian hormone (AMH) and the infertility treatment outcomes in infertile females with endometriosis versus the non-endometriosis infertile subject.
Materials and Methods: In this case-control study, 64 infertile females who referred to Shariati Hospital from April 2015 to November 2017 were enrolled. They were divided in two groups of 32 patients (endometriosis and non-endometriosis women). The anti-mullerian hormone level among all subjects was determined, treatment outcomes were evaluated and association between these factors was assessed.
Results: It was seen that the anti-mullerian hormone (p=0.06), the number of retrieved oocytes (p=0.7) and embryos (p=0.7), implantation rate (p=0.6) and clinical pregnancy rate (p=0.9) were similar between two groups. In patients with stage 3 or 4 endometriosis who had lower serum AMH level significantly (p=0.001) less oocytes were retrieved (p=0.001) and less transferrable embryos (p=0.03) were achieved. However, implantation and pregnancy rates did not differ (p=0.7) (p=0.6).
Conclusion: Totally, according to the obtained results, it may be concluded that ovarian reserve has more significant role in predicting infertility treatment outcome rather than receptive endometrium.
Objective: Current study was conducted to determine the association between level of anti-mullerian hormone (AMH) and the infertility treatment outcomes in infertile females with endometriosis versus the non-endometriosis infertile subject.
Materials and Methods: In this case-control study, 64 infertile females who referred to Shariati Hospital from April 2015 to November 2017 were enrolled. They were divided in two groups of 32 patients (endometriosis and non-endometriosis women). The anti-mullerian hormone level among all subjects was determined, treatment outcomes were evaluated and association between these factors was assessed.
Results: It was seen that the anti-mullerian hormone (p=0.06), the number of retrieved oocytes (p=0.7) and embryos (p=0.7), implantation rate (p=0.6) and clinical pregnancy rate (p=0.9) were similar between two groups. In patients with stage 3 or 4 endometriosis who had lower serum AMH level significantly (p=0.001) less oocytes were retrieved (p=0.001) and less transferrable embryos (p=0.03) were achieved. However, implantation and pregnancy rates did not differ (p=0.7) (p=0.6).
Conclusion: Totally, according to the obtained results, it may be concluded that ovarian reserve has more significant role in predicting infertility treatment outcome rather than receptive endometrium.
Type of Study: Short Research Reports |
References
1. Hosseini E, Nikmard F, Aflatoonian B, Vesali S, Alenabi T, Aflatoonian A, et al. Controlled ovarian stimulation in endometriosis patients can be individualized by anti-mullerian hormone levels. Acta Endocrinologica 2017; 13: 195-202. [DOI:10.4183/aeb.2017.195]
2. La Marca A, Broekmans FJ, Volpe A, Fauser BC, Macklon NS, ESHRE Special Interest Group for Reproductive Endocrinology-AMH Round Table. Anti-Müllerian hormone (AMH): what do we still need to know? Hum Reprod 2009; 24: 2264-2275. [DOI:10.1093/humrep/dep210]
3. Wang J, Dicken C, Lustbader JW, Tortoriello DV. Evidence for a Müllerian-inhibiting substance autocrine/paracrine system in adult human endometrium. Fertil Steril 2009; 91: 1195-1203. [DOI:10.1016/j.fertnstert.2008.01.028]
4. Boccellino M, Quagliuolo L, Verde A, La Porta R, Crispi S, Piccolo MT, et al. In vitro model of stromal and epithelial immortalized endometriotic cells. J Cell Biochem 2012; 113: 1292-1301. [DOI:10.1002/jcb.24000]
5. Prieto L, Quesada JF, Cambero O, Pacheco A, Pellicer A, Codoceo R, et al. Analysis of follicular fluid and serum markers of oxidative stress in women with infertility related to endometriosis. Fertil Steril 2012; 98: 126-130. [DOI:10.1016/j.fertnstert.2012.03.052]
6. Yoo JH, Cha SH, Park CW, Kim JY, Yang KM, Song IO, et al. Serum anti-Müllerian hormone is a better predictor of ovarian response than FSH and age in IVF patients with endometriosis. Clin Exp Reprod Med 2011; 38: 222-227. [DOI:10.5653/cerm.2011.38.4.222]
7. Mansour G, Sharma RK, Agarwal A, Falcone T. Endometriosis-induced alterations in mouse metaphase II oocyte microtubules and chromosomal alignment: a possible cause of infertility. Fertil Steril 2010; 94: 1894-1899. [DOI:10.1016/j.fertnstert.2009.09.043]
8. Garrido N, Navarro J, Remohí J, Simón C, Pellicer A. Follicular hormonal environment and embryo quality in women with endometriosis. Hum Reprod Update 2000; 6: 67-74. [DOI:10.1093/humupd/6.1.67]
9. Xiao Y, Sun X, Yang X, Zhang J, Xue Q, Cai B, et al. Leukemia inhibitory factor is dysregulated in the endometrium and uterine flushing fluid of patients with adenomyosis during implantation window. Fertil Steril 2010; 94: 85-89. [DOI:10.1016/j.fertnstert.2009.03.012]
10. Dimitriadis E, Stoikos C, Stafford-Bell M, Clark I, Paiva P, Kovacs G, et al. Interleukin-11, IL-11 receptorα and leukemia inhibitory factor are dysregulated in endometrium of infertile women with endometriosis during the implantation window. J Reprod Immunol 2006; 69: 53-64. [DOI:10.1016/j.jri.2005.07.004]
11. Lu H, Yang X, Zhang Y, Lu R, Wang X. Epigenetic disorder may cause downregulation of HOXA10 in the eutopic endometrium of fertile women with endometriosis. Reprod Sci 2013; 20: 78-84. [DOI:10.1177/1933719112451146]
12. Paskulin DD, Cunha-Filho JS, Souza CA, Bortolini MC, Hainaut P, Ashton-Prolla P. TP53 PIN3 and PEX4 polymorphisms and infertility associated with endometriosis or with post-in vitro fertilization implantation failure. Cell Death Dis 2012; 3: e392. [DOI:10.1038/cddis.2012.116]
13. Imai A, Takagi A, Tamaya T. Gonadotropin-releasing hormone analog repairs reduced endometrial cell apoptosis in endometriosis in vitro. Ame J Obstet Gynecol 2000; 182: 1142-1146. [DOI:10.1067/mob.2000.104804]
14. Lessey BA. Medical management of endometriosis and infertility. Fertil Steril 2000; 73: 1089-1096. [DOI:10.1016/S0015-0282(00)00519-7]
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
